Oct 13, 2014
RONSEN passed Turkish GMP Re-audit and renewed GMP certificate
RONSEN today announced that received the GMP certificate issued by Turkish MOH.
The on-site audit by Turkish MOH had been carried out from June 17th 2013 to June 21st, and the GMP certificate issued by Turkish MOH on Oct 13, 2014. 

RONSEN got Turkish GMP certificate in 2008 at the first time and the IVIG (5% 100ml 5g/bottle)  brand name as RonsenGlob was marketed in Turkey as the initial product in 2010. There are more than 750 kg RonsenGlob has been sold in Turkey till Dec 2014.

Our products also have been registered in India, Sri Lanka, Salvador, Paraguay, Peru… 
With advanced manufacture facilities and strict quality management system, RONSEN will keep provide the safe and effective products to customers worldwide.

About Ronsen
Chengdu Rongsheng Pharmaceuticals Co. Ltd. (Ronsen), is a wholly-owned subsidiary of China National Pharmaceutical Group Corporation, SINOPHARM, who is the state-owned and the largest enterprise of health industry in China. Ronsen is a specialty plasma protein products company that aims to identify, develop and commercialize important, new, Plasma protein products that help to save lives by preventing or treating serious medical conditions.
RONSEN is also an open enterprise with global vision. We keep close cooperative relationship with the leading enterprises and research institutes all over the world.

Aug 5, 2014
Ronsen Received GSP Certificate
Ronsen today announced that has received the Good Supply Practice (GSP) Certificate issued by Sichuan Food and Drug Administration (FDA). 
From July 1, 2014 to July 3, 2014, Ronsen has been audited by the inspectors of Sichuan FDA, after the on-site inspection, the inspectors make a conclusion that Ronsen is a pharmaceutical supply enterprise with complete organization structure, perfect file system, modern facilities, full personnel training and efficient quality management system.


About Ronsen
Chengdu Rongsheng Pharmaceuticals Co. Ltd. (Ronsen), is a wholly-owned subsidiary of China National Pharmaceutical Group Corporation, SINOPHARM, who is the state-owned and the largest enterprise of health industry in China. Ronsen is a specialty plasma protein products company that aims to identify, develop and commercialize important, new, Plasma protein products that help to save lives by preventing or treating serious medical conditions.
RONSEN is also an open enterprise with global vision. We keep close cooperative relationship with the leading enterprises and research institutes all over the world.